Marinus Pharmaceuticals is a company that provides Medicine, Ganaxolone, Allosteric modulator and more. Marinus Pharmaceuticals is headquartered in United States Connecticut. Marinus Pharmaceuticals was founded in 2003. and was founded by Harry H. Penner. Marinus Pharmaceuticals has a total of 162 patents and 1 literature
Related Topics
MedicineGanaxoloneAllosteric modulatorDrugPain disorderEpilepsyAntidepressantClinical trialClobazamBiopharmaceuticalFragile X syndromeBenzodiazepineVigabatrinRufinamideLacosamideEslicarbazepine acetateMidazolamPerampanelCarbamazepineIvacaftor
Marinus Pharmaceuticals is in the industry of:Pharmaceutical and Medicine ManufacturingDrugs and Druggists' Sundries Merchant Wholesalers
What technical fields has Marinus Pharmaceuticals researched?
Marinus Pharmaceuticals has researched the technical fields related toMedicineGanaxoloneAllosteric modulatorDrugPain disorderEpilepsyAntidepressantClinical trialClobazamBiopharmaceuticalFragile X syndromeBenzodiazepineVigabatrinRufinamideLacosamideEslicarbazepine acetateMidazolamPerampanelCarbamazepineIvacaftor
What is Marinus Pharmaceuticals's total number of patents?
Marinus Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of ganaxolone, offering a new...
What is Marinus Pharmaceuticals's official website?